PMC:7546716 / 12754-13192 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T223","span":{"begin":0,"end":8},"obj":"Body_part"},{"id":"T224","span":{"begin":125,"end":127},"obj":"Body_part"},{"id":"T225","span":{"begin":257,"end":281},"obj":"Body_part"},{"id":"T226","span":{"begin":276,"end":281},"obj":"Body_part"},{"id":"T227","span":{"begin":372,"end":377},"obj":"Body_part"},{"id":"T228","span":{"begin":382,"end":406},"obj":"Body_part"},{"id":"T229","span":{"begin":401,"end":406},"obj":"Body_part"}],"attributes":[{"id":"A223","pred":"fma_id","subj":"T223","obj":"http://purl.org/sig/ont/fma/fma67257"},{"id":"A224","pred":"fma_id","subj":"T224","obj":"http://purl.org/sig/ont/fma/fma86578"},{"id":"A225","pred":"fma_id","subj":"T225","obj":"http://purl.org/sig/ont/fma/fma273565"},{"id":"A226","pred":"fma_id","subj":"T226","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A227","pred":"fma_id","subj":"T227","obj":"http://purl.org/sig/ont/fma/fma68646"},{"id":"A228","pred":"fma_id","subj":"T228","obj":"http://purl.org/sig/ont/fma/fma273565"},{"id":"A229","pred":"fma_id","subj":"T229","obj":"http://purl.org/sig/ont/fma/fma68646"}],"text":"proteins involved in the trafficking and docking of cytolytic granules,1 and in patients who are predisposed to MAS, in whom IL-6 overexpression can reduce perforin and granzyme B concentration inside granules.31\nThe inability to kill infected or activated antigen-presenting cells in patients with either MAS or COVID-19 could result in persistent interactions between T cells and antigen presenting cells, culminating in hyperproduction"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T78","span":{"begin":112,"end":115},"obj":"Disease"},{"id":"T79","span":{"begin":306,"end":309},"obj":"Disease"},{"id":"T80","span":{"begin":313,"end":321},"obj":"Disease"}],"attributes":[{"id":"A78","pred":"mondo_id","subj":"T78","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"},{"id":"A79","pred":"mondo_id","subj":"T79","obj":"http://purl.obolibrary.org/obo/MONDO_0015545"},{"id":"A80","pred":"mondo_id","subj":"T80","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"proteins involved in the trafficking and docking of cytolytic granules,1 and in patients who are predisposed to MAS, in whom IL-6 overexpression can reduce perforin and granzyme B concentration inside granules.31\nThe inability to kill infected or activated antigen-presenting cells in patients with either MAS or COVID-19 could result in persistent interactions between T cells and antigen presenting cells, culminating in hyperproduction"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T181","span":{"begin":178,"end":179},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"},{"id":"T182","span":{"begin":247,"end":256},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"},{"id":"T183","span":{"begin":276,"end":281},"obj":"http://purl.obolibrary.org/obo/GO_0005623"},{"id":"T184","span":{"begin":370,"end":377},"obj":"http://purl.obolibrary.org/obo/CL_0000084"},{"id":"T185","span":{"begin":401,"end":406},"obj":"http://purl.obolibrary.org/obo/GO_0005623"}],"text":"proteins involved in the trafficking and docking of cytolytic granules,1 and in patients who are predisposed to MAS, in whom IL-6 overexpression can reduce perforin and granzyme B concentration inside granules.31\nThe inability to kill infected or activated antigen-presenting cells in patients with either MAS or COVID-19 could result in persistent interactions between T cells and antigen presenting cells, culminating in hyperproduction"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T164","span":{"begin":0,"end":8},"obj":"Chemical"},{"id":"T165","span":{"begin":125,"end":127},"obj":"Chemical"},{"id":"T167","span":{"begin":257,"end":264},"obj":"Chemical"},{"id":"T168","span":{"begin":382,"end":389},"obj":"Chemical"}],"attributes":[{"id":"A164","pred":"chebi_id","subj":"T164","obj":"http://purl.obolibrary.org/obo/CHEBI_36080"},{"id":"A165","pred":"chebi_id","subj":"T165","obj":"http://purl.obolibrary.org/obo/CHEBI_63895"},{"id":"A166","pred":"chebi_id","subj":"T165","obj":"http://purl.obolibrary.org/obo/CHEBI_74072"},{"id":"A167","pred":"chebi_id","subj":"T167","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"},{"id":"A168","pred":"chebi_id","subj":"T168","obj":"http://purl.obolibrary.org/obo/CHEBI_59132"}],"text":"proteins involved in the trafficking and docking of cytolytic granules,1 and in patients who are predisposed to MAS, in whom IL-6 overexpression can reduce perforin and granzyme B concentration inside granules.31\nThe inability to kill infected or activated antigen-presenting cells in patients with either MAS or COVID-19 could result in persistent interactions between T cells and antigen presenting cells, culminating in hyperproduction"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T35","span":{"begin":382,"end":400},"obj":"http://purl.obolibrary.org/obo/GO_0019882"}],"text":"proteins involved in the trafficking and docking of cytolytic granules,1 and in patients who are predisposed to MAS, in whom IL-6 overexpression can reduce perforin and granzyme B concentration inside granules.31\nThe inability to kill infected or activated antigen-presenting cells in patients with either MAS or COVID-19 could result in persistent interactions between T cells and antigen presenting cells, culminating in hyperproduction"}

{"project":"LitCovid-PubTator","denotations":[{"id":"502","span":{"begin":125,"end":129},"obj":"Gene"},{"id":"503","span":{"begin":169,"end":179},"obj":"Gene"},{"id":"504","span":{"begin":80,"end":88},"obj":"Species"},{"id":"522","span":{"begin":285,"end":293},"obj":"Species"},{"id":"523","span":{"begin":217,"end":226},"obj":"Disease"},{"id":"524","span":{"begin":235,"end":243},"obj":"Disease"},{"id":"525","span":{"begin":313,"end":321},"obj":"Disease"}],"attributes":[{"id":"A502","pred":"tao:has_database_id","subj":"502","obj":"Gene:3569"},{"id":"A503","pred":"tao:has_database_id","subj":"503","obj":"Gene:3002"},{"id":"A504","pred":"tao:has_database_id","subj":"504","obj":"Tax:9606"},{"id":"A522","pred":"tao:has_database_id","subj":"522","obj":"Tax:9606"},{"id":"A523","pred":"tao:has_database_id","subj":"523","obj":"MESH:D007319"},{"id":"A524","pred":"tao:has_database_id","subj":"524","obj":"MESH:D007239"},{"id":"A525","pred":"tao:has_database_id","subj":"525","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"proteins involved in the trafficking and docking of cytolytic granules,1 and in patients who are predisposed to MAS, in whom IL-6 overexpression can reduce perforin and granzyme B concentration inside granules.31\nThe inability to kill infected or activated antigen-presenting cells in patients with either MAS or COVID-19 could result in persistent interactions between T cells and antigen presenting cells, culminating in hyperproduction"}

{"project":"2_test","denotations":[{"id":"33073244-30774631-66244547","span":{"begin":71,"end":72},"obj":"30774631"},{"id":"33073244-26251193-66244548","span":{"begin":210,"end":212},"obj":"26251193"}],"text":"proteins involved in the trafficking and docking of cytolytic granules,1 and in patients who are predisposed to MAS, in whom IL-6 overexpression can reduce perforin and granzyme B concentration inside granules.31\nThe inability to kill infected or activated antigen-presenting cells in patients with either MAS or COVID-19 could result in persistent interactions between T cells and antigen presenting cells, culminating in hyperproduction"}